Injective (INJ) is currently trading at $2.96, experiencing a 24-hour decline of 5.17%. The price has fluctuated between a daily high of $3.12 and a low of $2.88, indicating a relatively tight daily range of $0.24.

The trading volume over the past 24 hours stands at approximately 62.73 million, which reflects a Vol/Market Cap ratio of 21.24%, suggesting healthy trading activity. However, the short-term moving averages reveal a bearish trend, with the 21 SMA at $2.99 showing a decline of 1.07% and the 55 SMA at $3.11 down 4.79%.

Current RSI metrics further confirm the bearish sentiment; the 1-hour RSI is at 36, signaling oversold conditions, while the 7-day RSI is at 41, indicating a weak market momentum. Over the past week, INJ has dropped by 21.03%, and it has lost 27.73% in the past 30 days, reflecting a significant downtrend.

Fundamentally, INJ's all-time high of $52.62, reached on March 14, 2024, indicates a long-term potential, but the current price levels suggest a stark deviation from that peak. This prolonged bearish sentiment may deter new buyers, as technical indicators show resistance above $3.

Given the current price action, volume, and RSI signals, INJ is in a precarious position, making it more suitable for cautious investors. Therefore, the rating for Injective (INJ) is a Hold, as traders may want to wait for more favorable conditions or a potential reversal before entering or adding to positions.